Peptides and related compounds grouped for use in metabolic pathway and energy‑balance research, including models involving nutrient signaling and substrate utilization. This category is designed for controlled laboratory investigations of metabolic signaling mechanisms only, not for weight‑loss, fitness, or therapeutic applications. For Research Use Only. Not for human or animal use.
Showing all 27 results
5-amino 1-MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT) Reduced adiposity, smaller adipocytes, and lower cholesterol without suppressing food intake. Recent work also reports improved muscle strength and regenerative capacity.
5-Amino-1MQ is a groundbreaking peptide that accelerates fat loss, preserves muscle, and boosts vitality by inhibiting NNMT to enhance NAD+ and metabolism. Backed by preclinical research, it offers promising benefits for weight loss, anti-aging, and cognitive health, though human trials are needed to confirm its potential.
AOD-9604: Studied for Fat Metabolism, Weight Management & Metabolic Health
AOD-9604, a modified fragment of human growth hormone (HGH), has been studied for its potential role in supporting fat metabolism, promoting weight management, and influencing metabolic health. Unlike full HGH, AOD-9604 specifically targets lipolysis (fat breakdown) without impacting insulin sensitivity or muscle growth, making it a focus of research related to obesity and metabolic conditions. AOD-9604 may coagulate upon reconstitution, reach out to support if you need help with preventing this from occurring. This happens as an indicator of high quality purity with the compound.
AOD-9604: Studied for Fat Metabolism, Weight Management & Metabolic Health
AOD-9604, a synthetic peptide derived from human growth hormone (hGH), has garnered significant interest in research settings for its potential effects on adipose tissue metabolism and lipid regulation.
Cagrilintide is a novel amylin analog developed for weight loss and metabolic regulation. It mimics the effects of the natural hormone amylin, which is co-secreted with insulin and plays a key role in regulating appetite, slowing gastric emptying, and promoting satiety.
Cagrilintide is a novel amylin analog developed for weight loss and metabolic regulation. It mimics the effects of the natural hormone amylin, and plays a key role in regulating appetite, slowing gastric emptying, and promoting satiety.
The CJC-1295 (No DAC) and Ipamorelin blend, combining two synthetic peptides, is a research compound designed to stimulate growth hormone (GH) release through complementary mechanisms, offering a valuable tool for studying neuroendocrine regulation and metabolic pathways.
GLP-2, a dual GLP-1 and GIP receptor agonist, has been studied for its potential impact on metabolic health, weight management, and insulin sensitivity. Research has explored how this dual-acting compound may influence appetite regulation, fat metabolism, and glucose control—areas of growing interest in obesity and metabolic disorder studies.
GLP-2, a dual GLP-1 and GIP receptor agonist, has been studied for its potential impact on metabolic health, weight management, and insulin sensitivity. Research has explored how this dual acting compound may influence appetite regulation, fat metabolism, and glucose control areas of growing interest in obesity and metabolic disorder studies.
GLP-2 is a high-purity dual incretin agonist peptide designed to simultaneously target the GIP and GLP-1 receptors. This next-generation research tool is engineered for advanced laboratory models investigating appetite regulation, insulin sensitivity, and body composition. Each 30mg vial from Protide Health is supplied in a stable lyophilized form.
GLP-3 represents a significant milestone in metabolic research, functioning as a triple incretin agonist that simultaneously targets the GLP-1, GIP, and glucagon receptors. Clinical research into multi-receptor signaling suggests that GLP-3 may offer enhanced metabolic support in laboratory models, particularly in the areas of appetite regulation, fat reduction, energy expenditure, and liver fat normalization.
GLP-3, a triple incretin agonist, has demonstrated significant results in research models, with phase 2 trials showing up to 24.2% weight loss, a 2.02% HbA1c reduction, and up to 82% liver fat normalization. Studies also indicate its potential to reduce cardiovascular risk by 26.9% through lipid improvements and supported kidney function markers. Clinical research continues to explore the potential of multi-receptor peptides like GLP-3 as a central component of the evolving metabolic health landscape. As a next-generation GLP-1/GIP receptor agonist, research suggests it may offer advantages over earlier GLP-1 medications in areas like fat reduction, appetite regulation, and metabolic support.
GLP-3, a triple incretin agonist, achieves remarkable 24.2% weight loss, 2.02% HbA1c reduction, and up to 82% liver fat normalization in phase 2 trials. It also reduces cardiovascular risk by 26.9% through lipid improvements and supports kidney function. This high-purity compound is used in laboratory settings to investigate the synergistic effects of triple-receptor signaling on metabolic rate, glycemic control, and adipose tissue pathways. Each 20mg vial from Protide Health is supplied as a lyophilized powder to maintain maximum stability during long-term experimental protocols.
GLP-3 24mg peptide represents a sophisticated advancement in metabolic research, functioning as a triple hormone receptor agonist that simultaneously targets the GLP-1, GIP, and glucagon pathways. This concentrated 24mg format allows for comprehensive longitudinal studies into appetite regulation, thermogenesis, and hepatic fat normalization within controlled laboratory models. As a next-generation research tool, GLP-3 provides a multifaceted signaling profile that distinguishes it from traditional single or dual-receptor agonists. Each high-purity vial from Protide Health is supplied as a stable lyophilized powder.
GLP-3 peptide 30mg is an advanced triple hormone receptor agonist designed for high-precision metabolic research. By simultaneously targeting the GLP-1, GIP, and glucagon receptors, this synthetic compound allows researchers to investigate complex pathways involving appetite regulation, energy expenditure, and glycemic control in laboratory models. Each vial contains 30mg of high-purity, lyophilized powder.
GLP-3 is a pioneering triple hormone receptor agonist engineered for advanced research into metabolic health and energy regulation. This single peptide molecule provides simultaneous activation of the GLP-1, GIP, and glucagon receptors, allowing investigators to explore multi-pathway signals in obesity, glucose control, and liver fat research models. Each 40mg vial is supplied as a lyophilized powder.
What is GLP-3? GLP-3 is a synthetic research peptide designed to help labs study how multiple gut-hormone signals can work together in metabolic models. This GLP-3 peptide is supplied as a vial for controlled laboratory and preclinical research use. Because GLP-3 is studied in the same “multi-receptor” category as next-generation incretin agonists, it often appears…
IGF-1 LR3 is studied for its effects on muscle growth and recovery: A 15–20% increase in muscle fiber cross-sectional area in mice treated with 1 mg/kg/day for 14 days, linked to enhanced protein synthesis PMC, IGF-1 Muscle Repair
Lean Peptide Blend, combining GLP-3 10mg and Cagrilintide 10mg, is an innovative research tool investigated for its synergistic effects on weight management, glucose regulation, and metabolic health.
MOTS-c, a mitochondrial-encoded peptide, has emerged as a significant research compound due to its potential role in regulating metabolic homeostasis and cellular aging. Derived from the mitochondrial genome, this 16-amino-acid peptide is investigated in controlled studies for its effects on energy metabolism, insulin sensitivity, and longevity pathways.
What is MOTS-c? MOTS-c peptide 20mg is a synthetic research peptide that matches a short sequence naturally made inside the mitochondria, the “power plants” of cells. In this listing, MOTS-c peptide is supplied as a 20mg lyophilized (freeze-dried) powder in a single research vial for reconstitution and use in controlled lab models only. Researchers are…
Nicotinamide Adenine Dinucleotide (NAD+) is a vital coenzyme involved in numerous cellular processes, including energy production, DNA repair, and redox signaling, with emerging research exploring its therapeutic potential in age related and metabolic disorders.
Sermorelin, a synthetic peptide analog of growth hormone-releasing hormone (GHRH), is a valuable research tool investigated for its ability to stimulate growth hormone (GH) secretion in controlled laboratory settings. As a 29-amino-acid peptide, it mimics the endogenous GHRH to explore neuroendocrine regulation, metabolic processes, and tissue growth.
Tesamorelin: Muscle Growth, Fat Metabolism & Body Composition
Tesamorelin, a synthetic growth hormone-releasing hormone (GHRH) analog, has been studied for its potential role in stimulating natural growth hormone production, muscle growth, promoting fat metabolism, and supporting body composition.
Tesamorelin is a GHRH analog. Pre-clinical studies demonstrate a 3–4-fold increase in GH levels, 15–20% fat mass reduction, and 10–12% muscle growth, making it an interesting peptide for researchers looking to support muscle growth and fat loss.
Tesamorelin + Ipamorelin: Insights into Dual Pathway GH Secretagogue Synergy Introduction Tesamorelin and Ipamorelin are synthetic peptides that stimulate the release of growth hormone (GH) through distinct mechanisms within the hypothalamic–pituitary axis. Tesamorelin is an analog of growth hormone–releasing hormone (GHRH) with enhanced stability and half-life, while Ipamorelin is a selective growth hormone secretagogue that…
A tesamorelin–ipamorelin blend is a mechanistically coherent dual-receptor strategy to study GH pulsatility and its effects on visceral adiposity, fat, and metabolic biomarkers. Tesamorelin provides clinically demonstrated VAT and liver-fat signals, while ipamorelin contributes GH-selective GHSR activation
No products in the cart.
